Compare Charles River Laboratories Intl. Inc (CRL) vs iShares Silver Trust (SLV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Charles River Laboratories Intl. Inc vs iShares Silver Trust — how do they compare? Charles River Laboratories Intl. Inc trades at $231 (market cap $11.14B), while iShares Silver Trust trades at $52.57. The key difference: Charles River Laboratories Intl. Inc is trading nearer its 52-week high, iShares Silver Trust nearer its low. Which is the better fit depends on your goals.
| CRL | SLV | |
|---|---|---|
Market Cap | $11.14B | — |
Sector | Health | — |
52-Week High | $233.60 | $105.57 |
52-Week Low | $145.57 | $33.32 |
Enterprise Value | $14.00B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Charles River Laboratories (CRL) trades at $229.75, down 1.57% on the day, near its consensus price target of $229.80. The stock shows a bullish technical trend with strong moving average signals and support at $225. Fundamentally, CRL has beaten EPS estimates for three consecutive quarters but reported a net loss of $144.34 million in 2025, with negative profit margins. Recent news highlights collaborations in AI and NGS services, supporting growth prospects.
Outlook remains mixed: analyst consensus is strongly bullish with 72% buy ratings and a high target of $260, but profitability challenges and high P/E of 684.85 pose risks. Cash flow stability and strategic partnerships offer upside, while margin pressures and debt levels require monitoring for sustained recovery.
SLV (iShares Silver Trust) is trading at $52.16, down 3.32% amid broader precious metals weakness. The ETF shows bearish technical signals with moving averages and ADX indicators pointing lower, though RSI readings suggest potential oversold conditions. Recent news highlights silver's dual role as both industrial metal and store of value, with prices down 17.8% year-to-date according to Barron's (July 13, 2026).
Silver's outlook remains challenged by inflation fears and Fed policy uncertainty, though some analysts see potential for recovery to $55-60 range (StoneX Q3 Outlook, July 10, 2026). Key risks include dollar strength, industrial demand fluctuations, and ongoing geopolitical tensions affecting precious metals markets.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Charles River Laboratories Intl. Inc
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Read more on CRL →About iShares Silver Trust
The ETF seeks to reflect such performance before payment of the ETF's expenses and liabilities. It is not actively managed. The ETF does not engage in any activities designed to obtain a profit from, or to ameliorate losses caused by, changes in the price of silver.
Read more on SLV →
